The Vioxx recall is just the latest of several episodes this year that have prompted criticism of the FDA and Senate hearings. A panel talks about the drug approval process, post-marketing safety surveillance, and how the agency’s work affects Americans’ health and safety.


  • Dr. Jerry Avorn author of "Powerful Medicines," professor of medicine at Harvard Medical School, and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital in Boston
  • Sen. Charles Grassley (R-Iowa), ranking member of the Senate Finance Committee
  • Marc Kaufman reporter on the national desk of "The Washington Post"
  • Alan Goldhammer, PhD associate vice president for regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA)
  • Dr. Sandra Kweder deputy director of the FDA's Office of New Drugs

Related Links

Topics + Tags


comments powered by Disqus
Most Recent Shows

Friday News Roundup – International

Friday, Oct 09 2015Russia denies the U.S. claim that cruise missiles aimed at Syria hit Iran. Doctors Without Borders demands an independent inquiry on the Afghanistan hospital bombing. And a group of four Tunisian organizations wins the Nobel Peace Prize. A panel of journalists joins guest host Indira Lakshmanan for analysis of the week's top international news stories.

Friday News Roundup – Domestic

Friday, Oct 09 2015The House leadership postpones its speaker vote after Rep. Kevin McCarthy (R-Calif.) drops out. Hillary Clinton announces her opposition to the new Pacific trade agreement. And the head of Volkswagen U.S. testifies before Congress on the emissions scandal. Guest host Indira Lakshmanan and a panel of journalists discuss the week’s top national stories.